Anaplastic Astrocytoma Trials


Antineoplaston Therapy in Treating Patients With Brain Tumors

Antineoplaston Therapy in Treating Patients With Brain Tumors The recruitment status of this study is unknown because the information has not been verified recently. Verified June 2009 by Na…

Continue reading about Clinical Trial Antineoplaston Therapy in Treating Patients With Brain Tumors

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma This study is currently recruiting participants. Verified January 2011 by National …

Continue reading about Clinical Trial Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer The recruitment status of this study is unknown because the information has not been verified recentl…

Continue reading about Clinical Trial Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma (UCDCC#208) This study is ongoing, but not recruiting participants. First Rec…

Continue reading about Clinical Trial Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery This study is currently recruiting participants. …

Continue reading about Clinical Trial Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma The recruitment status of this study is unknown because the information has not been verified recently. Verified…

Continue reading about Clinical Trial Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors The recruitment status of this study is unknown because the information has not been verified recently. …

Continue reading about Clinical Trial Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma This study is ongoing, but not recruiting participants. First Receive…

Continue reading about Clinical Trial Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma This study is currently recruiting participants. Verified April 2012 by Sidney Kimmel Compre…

Continue reading about Clinical Trial Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Melphalan With BBBD in Treating Patients With Brain Malignancies

Melphalan With BBBD in Treating Patients With Brain Malignancies This study is ongoing, but not recruiting participants. First Received on November 11, 2005.   …

Continue reading about Clinical Trial Melphalan With BBBD in Treating Patients With Brain Malignancies